30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Providers & Services

Encompass Health Corp (EHC)

Track

Over the last 90 days, Encompass Health Corp. has seen significant insider selling, with a net value of -$3.03 million. Executives have been the primary sellers, contributing to a net executive selling value of -$3.03 million. There were no insider purchases recorded during this period. The stock price has remained relatively flat, with a 90-day change of 0.1%.
Stock chart
Ticker: EHC Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
2 sales — total 2,958,550 USD
Sale 15 May 2026
Value US$2,833,477.07 | Price 371.82 | Shares 57,553
Sale 15 May 2026
Value US$4,571,681.66 | Price 442.05 | Shares 9,393
Proposed sale 15 May 2026
Value US$2,970,428.49 | Price 334.29 | Shares 70,242
Sale 11 May 2026
Value US$71,309.92 | Price 104.56 | Shares 682
Proposed sale 11 May 2026
Value US$71,312.30 | Price 104.56 | Shares 682
Sale 9 Mar 2026
Value US$1,277,259.00 | Price 107.00 | Shares 11,937
Sale 11 Feb 2026
Value US$24,192.54 | Price 113.58 | Shares 213
Sale 11 Feb 2026
Value US$9,923,082.05 | Price 113.09 | Shares 87,745
Sale 11 Feb 2026
Value US$677,717.73 | Price 111.89 | Shares 6,057
Sale 11 Feb 2026
Value US$1,215,017.68 | Price 110.92 | Shares 10,954
Sale 11 Feb 2026
Value US$1,715,330.88 | Price 110.07 | Shares 15,584
Sale 11 Feb 2026
Value US$1,439,532.80 | Price 108.80 | Shares 13,231
Sale 11 Feb 2026
Value US$1,751,814.48 | Price 108.03 | Shares 16,216
Proposed sale 11 Feb 2026
Value US$16,738,961.00 | Price 111.59 | Shares 150,000
Sale 10 Feb 2026
Value US$301,766.48 | Price 107.62 | Shares 2,804
Proposed sale 10 Feb 2026
Value US$301,755.00 | Price 107.62 | Shares 2,804
Proposed sale 27 Aug 2025
Value US$126,061.80 | Price 123.59 | Shares 1,020
Sale 27 Aug 2025
Value US$126,061.80 | Price 123.59 | Shares 1,020
Proposed sale 20 May 2025
Value US$14,383,656.00 | Price 121.50 | Shares 118,384
Sale 20 May 2025
Value US$14,375,783.70 | Price 121.53 | Shares 118,290
Sale 20 May 2025
Value US$11,368.36 | Price 120.94 | Shares 94
Sale 6 May 2025
Value US$498,974.19 | Price 116.61 | Shares 4,279
Sale 29 Apr 2025
Value US$457,760.24 | Price 116.36 | Shares 3,934
Sale 29 Apr 2025
Value US$1,548,065.02 | Price 115.51 | Shares 13,402
Sale 29 Apr 2025
Value US$3,011,712.42 | Price 114.78 | Shares 26,239
Sale 29 Apr 2025
Value US$1,147,900.00 | Price 114.79 | Shares 10,000
Proposed sale 29 Apr 2025
Value US$1,705,539.42 | Price 114.79 | Shares 14,858
Proposed sale 29 Apr 2025
Value US$5,017,565.39 | Price 115.15 | Shares 43,575
Sale 13 Feb 2025
Value US$495,578.18 | Price 98.29 | Shares 5,042
Sale 13 Aug 2024
Value US$8,528.94 | Price 87.03 | Shares 98
Sale 13 Aug 2024
Value US$1,049,945.46 | Price 86.33 | Shares 12,162
Proposed sale 13 Aug 2024
Value US$1,058,520.17 | Price 86.34 | Shares 12,260
Sale 24 May 2024
Value US$850,200.00 | Price 85.02 | Shares 10,000
Sale 24 May 2024
Value US$850,200.00 | Price 85.02 | Shares 10,000
Proposed sale 22 May 2024
Value US$2,518,935.68 | Price 85.39 | Shares 29,500
Sale 6 May 2024
Value US$1,220,739.42 | Price 83.94 | Shares 14,543
Sale 6 May 2024
Value US$1,220,739.42 | Price 83.94 | Shares 14,543
Proposed sale 6 May 2024
Value US$1,224,520.00 | Price 84.20 | Shares 14,543
Buy 3 May 2024
Value US$167,460.00 | Price 83.73 | Shares 2,000
Buy 3 May 2024
Value US$167,460.00 | Price 83.73 | Shares 2,000
Sale 30 Apr 2024
Value US$3,745,151.52 | Price 83.27 | Shares 44,976
Proposed sale 30 Apr 2024
Value US$3,761,792.00 | Price 83.64 | Shares 44,976
Sale 13 Nov 2023
Value US$710,918.85 | Price 63.39 | Shares 11,215
Proposed sale 13 Nov 2023
Value US$710,914.36 | Price 63.39 | Shares 11,215
Sale 17 Aug 2023
Value US$577,096.52 | Price 69.58 | Shares 8,294
Sale 16 Aug 2023
Value US$1,799,949.80 | Price 71.06 | Shares 25,330
Proposed sale 16 Aug 2023
Value US$1,799,945.01 | Price 71.06 | Shares 25,330
Sale 10 Feb 2023
Value US$1,087,658.10 | Price 60.78 | Shares 17,895
Buy 31 Oct 2022
Value US$100,046.10 | Price 54.67 | Shares 1,830
Sale 17 Aug 2022
Value US$1,088,909.25 | Price 53.25 | Shares 20,449
Buy 6 May 2022
Value US$66,480.00 | Price 66.48 | Shares 1,000
Buy 2 Dec 2021
Value US$20,039.94 | Price 56.61 | Shares 354
Sale 8 Mar 2021
Value US$699,144.60 | Price 81.40 | Shares 8,589
Planned sale 17 Nov 2020
Value US$500,213.00 | Price 75.22 | Shares 6,650
Sale 28 May 2020
Value US$37,313.50 | Price 76.15 | Shares 490
Sale 28 May 2020
Value US$1,742,623.03 | Price 75.73 | Shares 23,011
Sale 15 May 2020
Value US$161,825.00 | Price 64.73 | Shares 2,500
Sale 14 May 2020
Value US$1,618,093.44 | Price 61.92 | Shares 26,132
Sale 12 Mar 2020
Value US$118,080.00 | Price 59.04 | Shares 2,000
Buy 12 Mar 2020
Value US$491,123.08 | Price 60.76 | Shares 8,083
Buy 12 Mar 2020
Value US$1,233,771.00 | Price 59.95 | Shares 20,580
Buy 12 Mar 2020
Value US$2,451,068.37 | Price 58.91 | Shares 41,607
Buy 12 Mar 2020
Value US$2,258,655.38 | Price 58.09 | Shares 38,882
Buy 12 Mar 2020
Value US$615,180.02 | Price 57.29 | Shares 10,738
Buy 12 Mar 2020
Value US$248,900.40 | Price 56.44 | Shares 4,410
Buy 12 Mar 2020
Value US$38,150.00 | Price 54.50 | Shares 700
Buy 11 Mar 2020
Value US$64,070.00 | Price 64.07 | Shares 1,000
Buy 11 Mar 2020
Value US$2,569,600.00 | Price 64.24 | Shares 40,000
Buy 5 Nov 2019
Value US$34,595.00 | Price 69.19 | Shares 500
Sale 1 May 2019
Value US$1,513,915.89 | Price 63.23 | Shares 23,943
Sale 1 May 2019
Value US$2,768,801.86 | Price 63.74 | Shares 43,439
Buy 7 Mar 2019
Value US$58,840.00 | Price 58.84 | Shares 1,000
Sale 14 Aug 2018
Value US$756,938.28 | Price 80.04 | Shares 9,457
Sale 3 Aug 2018
Value US$2,258,490.00 | Price 78.00 | Shares 28,955
Sale 14 May 2018
Value US$112,788.54 | Price 62.73 | Shares 1,798
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-18 2026-05-15 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
57,553 -0.9%
371.82
US$2,833,477 		57,553 -0.9% 371.82 US$2,833,477
2026-05-18 2026-05-15 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
9,393 +30.6%
442.05
US$4,571,682 		9,393 +30.6% 442.05 US$4,571,682
2026-05-15 2026-05-15 PrS Proposed sale
2.9
Douglas Edward Coltharp

Officer

Officer
70,242
334.29
US$2,970,428 		70,242 334.29 US$2,970,428
2026-05-12 2026-05-11 S Sale
3.2
Tuer Patrick William

EVP, Chief Operating Officer

Officer
682 -2.7%
104.56
US$71,310 		682 -2.7% 104.56 US$71,310
2026-05-11 2026-05-11 PrS Proposed sale
3.2
Patrick Tuer

Officer

Officer
682
104.56
US$71,312 		682 104.56 US$71,312
2026-03-10 2026-03-09 S Sale
Fay Edmund

Sr. Vice Pres. and Treasurer

Officer
11,937 -11.8%
107.00
US$1,277,259 		11,937 -11.8% 107.00 US$1,277,259
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
213 -0.1%
113.58
US$24,193 		213 -0.1% 113.58 US$24,193
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
87,745 -18.9%
113.09
US$9,923,082 		87,745 -18.9% 113.09 US$9,923,082
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
6,057 -1.3%
111.89
US$677,718 		6,057 -1.3% 111.89 US$677,718
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
10,954 -2.3%
110.92
US$1,215,018 		10,954 -2.3% 110.92 US$1,215,018
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
15,584 -3.1%
110.07
US$1,715,331 		15,584 -3.1% 110.07 US$1,715,331
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
13,231 -2.6%
108.80
US$1,439,533 		13,231 -2.6% 108.80 US$1,439,533
2026-02-12 2026-02-11 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
16,216 -3.1%
108.03
US$1,751,814 		16,216 -3.1% 108.03 US$1,751,814
2026-02-11 2026-02-11 PrS Proposed sale
3.4
Mark Tarr

Officer

Officer
150,000
111.59
US$16,738,961 		150,000 111.59 US$16,738,961
2026-02-10 2026-02-10 S Sale
3.2
Tuer Patrick William

EVP, Chief Operating Officer

Officer
2,804 -14.9%
107.62
US$301,766 		2,804 -14.9% 107.62 US$301,766
2026-02-10 2026-02-10 PrS Proposed sale
3.2
Patrick Tuer

Officer

Officer
2,804
107.62
US$301,755 		2,804 107.62 US$301,755
2025-08-27 2025-08-27 PrS Proposed sale
3.2
Patrick Tuer

Officer

Officer
1,020
123.59
US$126,062 		1,020 123.59 US$126,062
2025-08-27 2025-08-27 S Sale
3.2
Tuer Patrick William

EVP, Chief Operating Officer

Officer
1,020 -5.1%
123.59
US$126,062 		1,020 -5.1% 123.59 US$126,062
2025-05-20 2025-05-20 PrS Proposed sale
3.4
Mark Tarr

Officer

Officer
118,384
121.50
US$14,383,656 		118,384 121.50 US$14,383,656
2025-05-20 2025-05-20 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
118,290 -18.3%
121.53
US$14,375,784 		118,290 -18.3% 121.53 US$14,375,784
2025-05-20 2025-05-20 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
94 -0.0%
120.94
US$11,368 		94 -0.0% 120.94 US$11,368
2025-05-07 2025-05-06 S Sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
4,279 -26.4%
116.61
US$498,974 		4,279 -26.4% 116.61 US$498,974
2025-04-30 2025-04-29 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
3,934 -6.1%
116.36
US$457,760 		3,934 -6.1% 116.36 US$457,760
2025-04-30 2025-04-29 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
13,402 -17.3%
115.51
US$1,548,065 		13,402 -17.3% 115.51 US$1,548,065
2025-04-30 2025-04-29 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
26,239 -25.3%
114.78
US$3,011,712 		26,239 -25.3% 114.78 US$3,011,712
2025-04-30 2025-04-29 S Sale
1.6
Darby John Patrick

EVP, Gen Counsel & Secretary

Officer
10,000 -11.1%
114.79
US$1,147,900 		10,000 -11.1% 114.79 US$1,147,900
2025-04-29 2025-04-29 PrS Proposed sale
1.6
John Patrick Darby

Officer

Officer
14,858
114.79
US$1,705,539 		14,858 114.79 US$1,705,539
2025-04-29 2025-04-29 PrS Proposed sale
2.9
Douglas Edward Coltharp

Officer

Officer
43,575
115.15
US$5,017,565 		43,575 115.15 US$5,017,565
2025-02-13 2025-02-13 S Sale
2.0
Price Andrew L

Chief Accounting Officer

Officer
5,042 -6.8%
98.29
US$495,578 		5,042 -6.8% 98.29 US$495,578
2024-08-14 2024-08-13 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
98 -0.1%
87.03
US$8,529 		98 -0.1% 87.03 US$8,529
2024-08-14 2024-08-13 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
12,162 -8.2%
86.33
US$1,049,945 		12,162 -8.2% 86.33 US$1,049,945
2024-08-13 2024-08-13 PrS Proposed sale
2.9
Douglas Coltharp

Officer

Officer
12,260
86.34
US$1,058,520 		12,260 86.34 US$1,058,520
2024-05-24 2024-05-24 S Sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
10,000 -35.0%
85.02
US$850,200 		10,000 -35.0% 85.02 US$850,200
2024-05-24 2024-05-24 S Sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
10,000 -35.0%
85.02
US$850,200 		10,000 -35.0% 85.02 US$850,200
2024-05-22 2024-05-22 PrS Proposed sale
CHIDSEY JOHN

Officer

Officer
29,500
85.39
US$2,518,936 		29,500 85.39 US$2,518,936
2024-05-07 2024-05-06 S Sale
1.6
Darby John Patrick

EVP, Gen Counsel & Secretary

Officer
14,543 -14.6%
83.94
US$1,220,739 		14,543 -14.6% 83.94 US$1,220,739
2024-05-07 2024-05-06 S Sale
1.6
Darby John Patrick

EVP, Gen Counsel & Secretary

Officer
14,543 -14.6%
83.94
US$1,220,739 		14,543 -14.6% 83.94 US$1,220,739
2024-05-06 2024-05-06 PrS Proposed sale
1.6
John Patrick Darby

Officer

Officer
14,543
84.20
US$1,224,520 		14,543 84.20 US$1,224,520
2024-05-07 2024-05-03 B Purchase
3.0
CARMICHAEL GREG D
Non-Executive Director
2,000 +13.3%
83.73
US$167,460 		2,000 +13.3% 83.73 US$167,460
2024-05-07 2024-05-03 B Purchase
3.0
CARMICHAEL GREG D
Non-Executive Director
2,000 +13.3%
83.73
US$167,460 		2,000 +13.3% 83.73 US$167,460
2024-05-01 2024-04-30 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
44,976 -7.5%
83.27
US$3,745,152 		44,976 -7.5% 83.27 US$3,745,152
2024-04-30 2024-04-30 PrS Proposed sale
3.4
Mark J Tarr

CEO
44,976
83.64
US$3,761,792 		44,976 83.64 US$3,761,792
2023-11-14 2023-11-13 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
11,215 -8.8%
63.39
US$710,919 		11,215 -8.8% 63.39 US$710,919
2023-11-13 2023-11-13 PrS Proposed sale
2.9
Douglas Edward Coltharp

Officer

Officer
11,215
63.39
US$710,914 		11,215 63.39 US$710,914
2023-08-18 2023-08-17 S Sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
8,294 -26.4%
69.58
US$577,097 		8,294 -26.4% 69.58 US$577,097
2023-08-17 2023-08-16 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
25,330 -4.8%
71.06
US$1,799,950 		25,330 -4.8% 71.06 US$1,799,950
2023-08-16 2023-08-16 PrS Proposed sale
3.4
Mark J. Tarr

Officer

Officer
25,330
71.06
US$1,799,945 		25,330 71.06 US$1,799,945
2023-02-13 2023-02-10 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
17,895 -25.2%
60.78
US$1,087,658 		17,895 -25.2% 60.78 US$1,087,658
2022-11-01 2022-10-31 B Purchase
3.0
CARMICHAEL GREG D
Non-Executive Director
1,830 +21.0%
54.67
US$100,046 		1,830 +21.0% 54.67 US$100,046
2022-08-19 2022-08-17 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
20,449 -4.4%
53.25
US$1,088,909 		20,449 -4.4% 53.25 US$1,088,909
2022-05-09 2022-05-06 B Purchase
3.1
O'Connor Kevin J.
Non-Executive Director
1,000 +41.1%
66.48
US$66,480 		1,000 +41.1% 66.48 US$66,480
2021-12-02 2021-12-02 B Purchase
3.2
Williams Terrance
Non-Executive Director
354 +7.2%
56.61
US$20,040 		354 +7.2% 56.61 US$20,040
2021-03-09 2021-03-08 S Sale
2.0
Price Andrew L

Chief Accounting Officer

Officer
8,589 -11.9%
81.40
US$699,145 		8,589 -11.9% 81.40 US$699,145
2020-11-19 2020-11-17 PlS Planned sale
2.3
Charbonneau Elissa Joy

Chief Medical Officer

Officer
6,650 -24.8%
75.22
US$500,213 		6,650 -24.8% 75.22 US$500,213
2020-05-29 2020-05-28 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
490 -0.3%
76.15
US$37,314 		490 -0.3% 76.15 US$37,314
2020-05-29 2020-05-28 S Sale
2.9
COLTHARP DOUGLAS E

EVP & Chief Financial Officer

Officer
23,011 -12.7%
75.73
US$1,742,623 		23,011 -12.7% 75.73 US$1,742,623
2020-05-18 2020-05-15 S Sale
2.7
Jacobsmeyer Barbara Ann

President, Inpatient Hospitals

Officer
2,500 -5.3%
64.73
US$161,825 		2,500 -5.3% 64.73 US$161,825
2020-05-14 2020-05-14 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
26,132 -6.4%
61.92
US$1,618,093 		26,132 -6.4% 61.92 US$1,618,093
2020-03-16 2020-03-12 S Sale
1.8
CORRELL DONALD L
Non-Executive Director
2,000 -2.8%
59.04
US$118,080 		2,000 -2.8% 59.04 US$118,080
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
8,083 +4.4%
60.76
US$491,123 		8,083 +4.4% 60.76 US$491,123
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
20,580 +12.6%
59.95
US$1,233,771 		20,580 +12.6% 59.95 US$1,233,771
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
41,607 +34.3%
58.91
US$2,451,068 		41,607 +34.3% 58.91 US$2,451,068
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
38,882 +47.1%
58.09
US$2,258,655 		38,882 +47.1% 58.09 US$2,258,655
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
10,738 +14.9%
57.29
US$615,180 		10,738 +14.9% 57.29 US$615,180
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
4,410 +6.5%
56.44
US$248,900 		4,410 +6.5% 56.44 US$248,900
2020-03-13 2020-03-12 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
700 +1.0%
54.50
US$38,150 		700 +1.0% 54.50 US$38,150
2020-03-13 2020-03-11 B Purchase
3.4
HIGDON LEO I JR
Non-Executive Director
1,000 +1.4%
64.07
US$64,070 		1,000 +1.4% 64.07 US$64,070
2020-03-12 2020-03-11 B Purchase
3.9
Anthony April Kaye Bullock

CEO & President, Home Health

Officer
40,000 +149.6%
64.24
US$2,569,600 		40,000 +149.6% 64.24 US$2,569,600
2019-11-06 2019-11-05 B Purchase CURL YVONNE M Non-Executive Director
500 +0.7%
69.19
US$34,595 		500 +0.7% 69.19 US$34,595
2019-05-03 2019-05-01 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
23,943 -6.5%
63.23
US$1,513,916 		23,943 -6.5% 63.23 US$1,513,916
2019-05-03 2019-05-01 S Sale
3.4
Tarr Mark J

President & CEO

Executive Director
43,439 -10.6%
63.74
US$2,768,802 		43,439 -10.6% 63.74 US$2,768,802
2019-03-08 2019-03-07 B Purchase
3.4
HIGDON LEO I JR
Non-Executive Director
1,000 +1.5%
58.84
US$58,840 		1,000 +1.5% 58.84 US$58,840
2018-08-14 2018-08-14 S Sale Price Andrew L

Chief Accounting Officer

Officer
9,457 -12.7%
80.04
US$756,938 		9,457 -12.7% 80.04 US$756,938
2018-08-06 2018-08-03 S Sale Levy Cheryl B.

Chief Human Resources Officer

Officer
28,955 -42.3%
78.00
US$2,258,490 		28,955 -42.3% 78.00 US$2,258,490
2018-05-15 2018-05-14 S Sale Jacobsmeyer Barbara Ann

President, Inpatient Hospitals

Officer
1,798 -5.3%
62.73
US$112,789 		1,798 -5.3% 62.73 US$112,789
Explore more

More insider trading research around Encompass Health Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America